{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:40:28Z","timestamp":1794886828658,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0900804"],"award-info":[{"award-number":["2018YFA0900804"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970875"],"award-info":[{"award-number":["31970875"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["M21013"],"award-info":[{"award-number":["M21013"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ijbiomac.2021.08.177","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T01:36:56Z","timestamp":1630287416000},"page":"713-721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Conjugation of Zika virus EDIII with CRM197, 8-arm PEG and mannan for development of an effective Zika virus vaccine"],"prefix":"10.1016","volume":"190","author":[{"given":"Yunxia","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0005","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika virus envelope protein and its complex with a Flavivirus broadly protective antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0035-9203(52)90043-6","article-title":"Zika virus. II. Pathogenicity and physical properties","volume":"46","author":"Dick","year":"1952","journal-title":"Trans R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0015","doi-asserted-by":"crossref","first-page":"e00055","DOI":"10.1128\/MMBR.00055-16","article-title":"The antigenic structure of Zika virus and its relation to other Flaviviruses implications for infection and immunoprophylaxis","volume":"81","author":"Heinz","year":"2017","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0020","doi-asserted-by":"crossref","first-page":"O595","DOI":"10.1111\/1469-0691.12707","article-title":"Rapid spread of emerging Zika virus in the Pacific area","volume":"20","author":"Musso","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.medmal.2014.04.008","article-title":"Current Zika virus epidemiology and recent epidemics","volume":"44","author":"Ioos","year":"2014","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1590\/0074-02760150192","article-title":"First report of autochthonous transmission of Zika virus in Brazil","volume":"110","author":"Zanluca","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0035","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2471\/BLT.16.171082","article-title":"Zika: the origin and spread of a mosquito-borne virus","volume":"94","author":"Kindhauser","year":"2016","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0040","article-title":"Zika virus is a global public health emergency, declares WHO","volume":"352","author":"Gulland","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0045","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials","volume":"391","author":"Modjarrad","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0050","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41598-017-08247-9","article-title":"Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0055","doi-asserted-by":"crossref","first-page":"16021","DOI":"10.1038\/npjvaccines.2016.21","article-title":"In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine","volume":"1","author":"Muthumani","year":"2016","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0060","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0065","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4155\/tde-2016-0006","article-title":"mRNA vaccine delivery using lipid nanoparticles","volume":"7","author":"Reichmuth","year":"2016","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pep.2019.05.005","article-title":"Expression and purification of domain III proteins from Dengue and Zika viruses","volume":"162","author":"Corzo-Gomez","year":"2019","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0075","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.3389\/fimmu.2018.02464","article-title":"A recombinant subunit based Zika virus vaccine is efficacious in non-human primates","volume":"9","author":"Medina","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0080","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","article-title":"Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico","volume":"169","author":"Robbiani","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0090","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","article-title":"Recent advances of vaccine adjuvants for infectious diseases","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-018-0089-x","article-title":"Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want","volume":"3","author":"HogenEsch","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0110","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid a as a safe and effective vaccine adjuvant","volume":"65","author":"Casella","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0115","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.biopha.2018.06.026","article-title":"Efficacy and safety of immunological adjuvants. Where is the cut-off?","volume":"105","author":"Batista-Duharte","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0120","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2010.12.135","article-title":"Ag85B-ESAT-6 adjuvanted with IC31(R) promotes strong and long-lived mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection","volume":"29","author":"van Dissel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0125","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0130","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1016\/j.bmc.2017.09.027","article-title":"Conjugation of the CRM197-inulin conjugate significantly increases the immunogenicity of mycobacterium tuberculosis CFP10-TB10.4 fusion protein","volume":"25","author":"Hu","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0135","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2019.02.013","article-title":"Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A","volume":"164","author":"Wang","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0140","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1039\/C8MD00546J","article-title":"Synthesis and immunogenicity of the Mycobacterium tuberculosis arabinomannan-CRM197 conjugate","volume":"10","author":"Chang","year":"2019","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0145","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/acs.bioconjchem.7b00131","article-title":"Conjugation reaction with 8-arm PEG markedly improves the immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 fusion protein","volume":"28","author":"Sun","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0150","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.imbio.2008.11.004","article-title":"Influence of the mannose receptor in host immune responses","volume":"214","author":"Gazi","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0155","doi-asserted-by":"crossref","DOI":"10.1177\/0394632017742504","article-title":"Mannosylated T\/Tn with Freund's adjuvant induces cellular immunity","volume":"31","author":"Son","year":"2018","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0160","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.carbpol.2017.11.103","article-title":"Mannan and phosphomannan from Kuraishia capsulata yeast","volume":"181","author":"Ustyuzhanina","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2010.01.007","article-title":"Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen","volume":"143","author":"Slutter","year":"2010","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0170","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1021\/acs.molpharmaceut.6b00138","article-title":"Conjugation with an inulin-chitosan adjuvant markedly improves the immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 fusion protein","volume":"13","author":"Yu","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1423-0410.1979.tb02314.x","article-title":"Determination of polyethylene glycol-4000 and glycol-6000 in plasma protein preparations","volume":"37","author":"Skoog","year":"1979","journal-title":"Vox Sang."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ab.2004.12.001","article-title":"Carbohydrate analysis by a phenol-sulfuric acid method in microplate format","volume":"339","author":"Masuko","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0185","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1016\/j.vaccine.2007.07.037","article-title":"Characterization and immunogenicity of meningococcal group C conjugate vaccine prepared using hydrazide-activated tetanus toxoid","volume":"25","author":"Silverira","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0190","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.copbio.2020.06.015","article-title":"Engineering nanoparticulate vaccines for enhancing antigen cross-presentation","volume":"66","author":"Du","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0195","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1016\/j.vaccine.2017.04.052","article-title":"Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus","volume":"35","author":"Yang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0200","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.3389\/fimmu.2018.01964","article-title":"The challenges imposed by Dengue, Zika, and Chikungunya to Brazil","volume":"9","author":"de Andrade Zanotto","year":"2018","journal-title":"Front. Immunol."},{"issue":"suppl. 10","key":"10.1016\/j.ijbiomac.2021.08.177_bb0205","doi-asserted-by":"crossref","first-page":"S957","DOI":"10.1093\/infdis\/jix464","article-title":"Zika virus vaccine development","volume":"216","author":"Morabito","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2021.08.177_bb0210","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cell.2016.09.020","article-title":"Zika virus: immunity and vaccine development","volume":"167","author":"Pierson","year":"2016","journal-title":"Cell"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021018511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021018511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:06:36Z","timestamp":1758877596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813021018511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":42,"alternative-id":["S0141813021018511"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.08.177","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conjugation of Zika virus EDIII with CRM197, 8-arm PEG and mannan for development of an effective Zika virus vaccine","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.08.177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}